This page uses javascript to enable Google Analytics.

Skip Navigation
Multi Photo Banner
Bio Photo

Nadarajah Vigneswaran, BDS, DMD, Dr Med Dent


Title: Professor
Office: BBS-5320
Phone: 713-486-4410
Email: Nadarajah.Vigneswaran@uth.tmc.edu
Department/Administrative Area: Oral Pathology Diagnostics, Diagnostic and Biomedical Sciences
Education:
BDS | University of Peradeniya, Sri Lanka, 1980
DMD | University of Alabama School of Dentistry at Birmingham, 1997
DrMedDent | Immunopathology, University of Erlagen, Germany, 1988

Nadarajah Vigneswaran, BDS, DMD, DrMedDent, is a professor in the Department of Diagnostic and Biomedical Sciences at The University of Texas School of Dentistry at Houston. He earned a Bachelor of Dental Surgery (BDS) degree from the University of Peradeniya, Sri Lanka, and a DMD from the University of Alabama School of Dentistry at Birmingham. He obtained his DrMedDent degree in immunopathology from the University Erlangen, Germany. Dr. Vigneswaran completed a three-year Oral and Maxillofacial Pathology Residency at Emory University and a one-year Fellowship in Oral and Maxillofacial Pathology and Oral Oncology at the University of Alabama at Birmingham. He is licensed to practice dentistry in both Texas and Alabama.

Dr. Vigneswaran is a Fellow of the American Academy of Oral and Maxillofacial Pathology and a Diplomate of the American Board of Oral and Maxillofacial Pathology.  He practices surgical and clinical oral pathology at UTSD, where he is  Course Director for the Systemic Pathology Course. He is a two-time winner of Dean’s Teaching Excellence Awards.

Dr. Vigneswaran conducts clinical, translational and basic research in oral precancers and cancers. He is currently involved in multiple collaborative clinical research projects with scientists and clinicians from Rice University, The University of Texas M.D. Anderson Cancer Center and The University of Texas Health Science Center at San Antonio, focusing on the development and characterization of novel non-invasive diagnostic devices and chemoprevention agents for oral precancer and cancer. He is actively involved in basic-science research, focusing on the development of novel animal models, methods and strategies to study oral cancer development and metastasis.

His current basic research involves (1) Therapeutic delivery of siRNA to a mouse model of oral cancer and (2) Characterization oral precancer and cancer-specific microRNA signatures using a mouse model of oral tongue carcinogenesis. His current research efforts are funded through the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. Dr. Vigneswaran has published more than 75 research articles and clinical reports in highly reputable journals. He is co-author of three book chapters, including one in the medical textbook "Vasculitis."